RN7SL700P

Across TCGA pan-cancer cohorts, RN7SL700P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SL700P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SL700P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL700P expression acts as an unfavorable survival marker.

BRCA, SKCM, and BLCA are the cancer types where RN7SL700P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	III,IV	0.140	0.833	<.001	72	view →
SKCM	OS	Tertile	III,IV	0.072	0.814	<.001	72	view →
BLCA	DFS	Tertile	IV	0.096	0.484	<.001	36	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
KIRP	DFS	Tertile	All	0.370	0.860	<.001	18	view →
ESCA	DFS	Tertile	III,IV	0.090	0.449	<.001	18	view →
THYM	DFS	Tertile	All	0.107	0.884	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SL700P–BRCA (OS)

Open the BRCA breakdown →